We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGA icon
1201
SIGA Technologies
SIGA
$240M
$1K ﹤0.01%
172
SMMT icon
1202
Summit Therapeutics
SMMT
$10B
$1K ﹤0.01%
155
SNAP icon
1203
PUT
Snap
SNAP
$8.02B
$1K ﹤0.01%
1,085
SPRO icon
1204
Spero Therapeutics
SPRO
$69.5M
$1K ﹤0.01%
51
SYRE icon
1205
Spyre Therapeutics
SYRE
$8.68B
$1K ﹤0.01%
4
TCRT icon
1206
Alaunos Therapeutics
TCRT
$4.64M
$1K ﹤0.01%
3
TXMD icon
1207
TherapeuticsMD
TXMD
$23.8M
$1K ﹤0.01%
12
UBX
1208
DELISTED
Unity Biotechnology
UBX
$1K ﹤0.01%
12
URGN icon
1209
UroGen Pharma
URGN
$1.99B
$1K ﹤0.01%
48
VSTM icon
1210
Verastem
VSTM
$547M
$1K ﹤0.01%
27
VYNE icon
1211
VYNE Therapeutics
VYNE
$19.1M
0
WVE icon
1212
Wave Life Sciences
WVE
$1.13B
$1K ﹤0.01%
99
XBIT icon
1213
XBiotech
XBIT
$69.2M
$1K ﹤0.01%
64
XENE icon
1214
Xenon Pharmaceuticals
XENE
$6.28B
$1K ﹤0.01%
66
QTTB icon
1215
Q32 Bio
QTTB
$467M
$1K ﹤0.01%
6
TECX
1216
Tectonic Therapeutic
TECX
$562M
$1K ﹤0.01%
7
SYRS
1217
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
10
PSTX
1218
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
116
EGRX
1219
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
FUSN
1220
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
78
MRNS
1221
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58
EIGR
1222
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
2
GMDA
1223
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1K ﹤0.01%
93
CBAY
1224
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
152
BCEL
1225
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1K ﹤0.01%
65

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.